Project Details
Description
Blood-Brain Barrier Penetration of E6201, a Novel MEK1 Inhibitor
| Status | Finished |
|---|---|
| Effective start/end date | 9/12/16 → 4/30/17 |
Funding
- STRATEGIA THERAPEUTICS, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.